ONCE Spark Therapeutics, Inc.

64.49
-0.08  -0.12%
Previous Close 64.57
Open 64.05
Price To book 5.52
Market Cap 1.98B
Shares 30,773,000
Volume 271,640
Short Ratio 11.38
Av. Daily Volume 397,671

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Phase 1/2 trial to be initiated 4Q 2016 with initial data due mid 2017.
SPK-8011
Hemophilia A
Phase 1/2 updated data at ASH 2016. Further update due 1H 2017.
SPK-9001
Hemophilia B
Phase 1/2 dosing commenced 1Q 2015. Initial data due early 2017.
SPK-7001 (SPK-CHM)
Choroideremia
BLA filing due early 2017.
SPK-RPE65
Inherited retinal dystrophies

Latest News

  1. Spark Therapeutics to Host Conference Call on Wednesday, Feb. 22 at 8:30 a.m. to Discuss 2016 Results
  2. Coverage initiated on Spark Therapeutics by Leerink Partners
  3. Spark Therapeutics to Participate in Multiple February Conferences
  4. Spark Therapeutics, Inc. breached its 50 day moving average in a Bearish Manner : ONCE-US : January 18, 2017
  5. Spark Therapeutics Announces U.S. Orphan Drug Designation Amendment and Study Updates for Lead Investigational Gene Therapy
  6. Spark Gets A Check From Pfizer And A Downgrade From Vetr
  7. Spark Therapeutics, Inc. – Value Analysis (NASDAQ:ONCE) : January 5, 2017
  8. Company News for January 05, 2017
  9. Spark Therapeutics Gets $15M Milestone Payment from Pfizer
  10. Spark reels in second $15M payment from Pfizer
  11. Spark Therapeutics, Inc. breached its 50 day moving average in a Bullish Manner : ONCE-US : January 4, 2017
  12. Spark Therapeutics Announces $15 Million Milestone Payment from Pfizer for Progress in Hemophilia B Gene Therapy Program
  13. Spark Therapeutics to Participate in J.P. Morgan Healthcare Conference
  14. Massive Bill Ackman Trade Highlights Insider Selling: Valeant Pharmaceuticals, Starbucks, Schlumberger, Validus and More
  15. Is MRC Global Inc (MRC) A Good Stock To Buy?
  16. SPARK THERAPEUTICS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement
  17. Spark Therapeutics, Inc. breached its 50 day moving average in a Bearish Manner : ONCE-US : December 8, 2016
  18. Hedge Funds Aren’t Crazy About Spark Therapeutics Inc (ONCE) Anymore
  19. Rivals Kite Pharma, Juno Therapeutics Tank On Cancer Data; Spark Flies
  20. SPARK THERAPEUTICS, INC. Files SEC form 8-K, Change in Directors or Principal Officers